Special Analysis: Addressing Key Concerns Around the FDA’s Final LDTs Rule
Experts answer key questions related to laboratory-developed test regulation during G2 Intelligence webinar.
Practical, “What-to-Do” and “How-to-Do-It” Help to Comply with the Latest State & Federal Laws, Rules & Regulations that Affect Your Diagnostic Lab or Pathology Practice
Experts answer key questions related to laboratory-developed test regulation during G2 Intelligence webinar.
A new OIG Advisory Opinion sheds some light on how to properly structure these arrangements in a hospital inpatient setting.
Labs and other companies need a proactive strategy for dealing with romance and fraternization between employees.
Here’s a template for a conflict of interest policy that you can adapt for your lab based on its specific situation and HR policies.
Having employees involved in office romances disclose their relationship and follow key ground rules can help avoid negative impacts on the lab.
It’s important to implement a policy that allows you to keep control over the potential issues romantic relationships can cause in the lab.
In this month’s Labs in Court roundup, a medical device company and genetic testing company each win key victories.
An overview of PAMA and key aspects lab compliance officers should be aware of to help ensure compliance.
Recent OIG report suggests some labs might have gamed Medicare coverage rules in 2020 by billing for unusually high numbers of such tests.
In our latest roundup, schemes involving cancer genetic testing and kickbacks remain the most common, but there were some surprises.
Key cases over the last month include a CGx testing kickback scheme, false billing, and violations of a non-compete clause and HIPAA.